Pfizer Inc. Credit Rating

Resultados 1 - 50 de 209

Página de 5 Next

Filtrar por:

Fecha	Tipo de Informe	Título	Fuente
26 Mar 2024	Peer Snapshot	Pfizer Inc. - December 2023 (LTM): Peer Snapshot	Moody's Investors Service
18 Dec 2023	Peer Snapshot	Pfizer Inc. - October 2023 (LTM): Peer Snapshot	Moody's Investors Service
14 Dec 2023	Credit Opinion	Pfizer Inc.: Update to credit analysis after downgrade to A2	Moody's Investors Service
13 Dec 2023	Rating Action	Moody's downgrades Pfizer to A2; affirms Prime-1; stable outlook	Moody's Investors Service
17 Oct 2023	Announcement	Moody's says Pfizer's Lower Covid-19 Product Demand is Credit Negative	Moody's Investors Service
14 Sep 2023	Credit Opinion	Pfizer Inc.: Steady pipeline execution ahead of COVID booster vaccinations and pending Seagen acquisition	Moody's Investors Service
13 Sep 2023	Peer Snapshot	Pfizer Inc. - July 2023 (LTM): Peer Snapshot	Moody's Investors Service
27 Jul 2023	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
26 Jun 2023	Peer Snapshot	Pfizer Inc. - April 2023 (LTM): Peer Snapshot	Moody's Investors Service
15 May 2023	Rating Action	Moody's assigns A1 rating to Pfizer's notes; outlook negative	Moody's Investors Service
30 Mar 2023	Peer Snapshot	Pfizer Inc. - December 2022 (LTM): Peer Snapshot	Moody's Investors Service
14 Mar 2023	Credit Opinion	Pfizer Inc.: Update following Seagen acquisition announcement and outlook revision to negative	Moody's Investors Service
13 Mar 2023	Rating Action	Moody's affirms Pfizer's A1 rating; revises outlook to negative	Moody's Investors Service
19 Dec 2022	Peer Snapshot	Pfizer Inc. - October 2022 (LTM): Peer Snapshot	Moody's Investors Service
18 Nov 2022	Credit Opinion	Pfizer Inc.: Update to credit analysis following upgrade to A1	Moody's Investors Service
18 Nov 2022	Rating Action	Moody's upgrades Pfizer to A1; outlook is stable	Moody's Investors Service
06 Oct 2022	Peer Snapshot	Pfizer Inc. - July 2022 (LTM): Peer Snapshot	Moody's Investors Service
04 Oct 2022	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
23 Jun 2022	Peer Snapshot	Pfizer Inc. - April 2022 (LTM): Peer Snapshot	Moody's Investors Service
20 May 2022	Credit Opinion	Pfizer Inc.: Capital deployment ongoing, intended to help fill patent cliff	Moody's Investors Service
10 May 2022	Announcement	Moody's: Pfizer's Biohaven acquisition helps mitigate late-decade patent cliff	Moody's Investors Service
10 May 2022	Issuer Comment	Pfizer Inc.: Biohaven acquisition helps mitigate late-decade patent cliff	Moody's Investors Service
29 Mar 2022	Peer Snapshot	Pfizer Inc. - December 2021 (LTM): Peer Snapshot	Moody's Investors Service
15 Dec 2021	Credit Opinion	Pfizer Inc.: Update to credit analysis following positive outlook	Moody's Investors Service
14 Dec 2021	Rating Action	Moody's affirms Pfizer's A2 rating; revises outlook to positive	Moody's Investors Service
03 Dec 2021	Peer Snapshot	Pfizer Inc. - October 2021 (LTM): Peer Snapshot	Moody's Investors Service
12 Nov 2021	Credit Opinion	Pfizer Inc.: High COVID-related revenues will continue into 2022	Moody's Investors Service
10 Nov 2021	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Pfizer Inc.	Moody's Investors Service
14 Sep 2021	Peer Snapshot	Pfizer Inc. - July 2021 (LTM): Peer Snapshot	Moody's Investors Service
16 Aug 2021	Rating Action	Moody's assigns A2 to Pfizer's sr. notes; stable outlook	Moody's Investors Service
17 Jun 2021	Peer Snapshot	Pfizer Inc. - April 2021 (LTM): Peer Snapshot	Moody's Investors Service
14 May 2021	Credit Opinion	Pfizer Inc.: COVID-19 vaccine will drive high sales and modest financial leverage at least near-term	Moody's Investors Service
02 Apr 2021	Peer Snapshot	Pfizer Inc. - December 2020 (LTM): Peer Snapshot	Moody's Investors Service
15 Dec 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Pfizer Inc.	Moody's Investors Service
13 Dec 2020	Announcement	Moody's: Pfizer's US vaccine authorization is credit positive	Moody's Investors Service
25 Nov 2020	Peer Snapshot	Pfizer Inc. - September 2020 (LTM): Peer Snapshot	Moody's Investors Service
17 Nov 2020	Credit Opinion	Pfizer Inc.: Update following downgrade to A2	Moody's Investors Service
16 Nov 2020	Rating Action	Moody's downgrades Pfizer to A2 from A1 following Upjohn separation; stable outlook	Moody's Investors Service
09 Nov 2020	Announcement - Servicer	Moody's: Pfizer's COVID-19 vaccine efficacy data credit positive	Moody's Investors Service
09 Nov 2020	Issuer Comment	Pfizer Inc.: COVID-19 efficacy data has positive social implications and revenue opportunities	Moody's Investors Service
26 Oct 2020	Rating Action	Moody's assigns P-1 rating to Pfizer's euro CP program	Moody's Investors Service
01 Sep 2020	Peer Snapshot	Pfizer Inc. - June 2020 (LTM): Peer Snapshot	Moody's Investors Service
31 Jul 2020	Credit Opinion	Pfizer Inc.: Update to credit analysis - rating review continues with Upjohn separation pending	Moody's Investors Service
02 Jun 2020	Peer Snapshot	Pfizer Inc. - March 2020 (LTM): Peer Snapshot	Moody's Investors Service
18 May 2020	Rating Action	Moody's assigns A1 to Pfizer's notes; on review for downgrade	Moody's Investors Service
06 Apr 2020	Peer Snapshot	Pfizer Inc. - December 2019 (LTM): Peer Snapshot	Moody's Investors Service
25 Mar 2020	Rating Action	Moody's assigns A1 to Pfizer's notes, on review for downgrade	Moody's Investors Service
31 Jan 2020	Credit Opinion	Pfizer Inc.: Update to credit analysis - rating review continues with Upjohn separation pending	Moody's Investors Service
14 Jan 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Pfizer Inc.	Moody's Investors Service
02 Dec 2019	Peer Snapshot	Pfizer Inc. - September 2019 (LTM): Peer Snapshot	Moody's Investors Service

Resultados 1 - 50 de 209

Página de 5 Next

Informes & Calificaciones

Productos & Soluciones

Noticias & Eventos

Usuarios Registrados

No se ha registrado?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: